Hot Pursuit     25-Jan-16
Strong Q3 numbers boost Unichem Lab
Unichem Laboratories surged 4.8% to Rs 239.10 at 10:31 IST on BSE after net profit spurted 897.1% to Rs 20.54 crore on 15.6% growth in net sales to Rs 303.93 crore in Q3 December 2015 over Q3 December 2014.
The result was announced on Saturday, 23 January 2016.

Meanwhile, the S&P BSE Sensex was up 162.42 points or 0.66% at 24,598.08.

On BSE, so far 60,000 shares were traded in the counter as against average daily volume of 22,278 shares in the past one quarter. The stock hit a high of Rs 245.90 and a low of Rs 238 so far during the day. The stock had hit a record high of Rs 334 on 6 October 2015. The stock had hit a 52-week low of Rs 174 on 8 June 2015. The stock had underperformed the market over the past one month till 22 January 2016, sliding 14.15% compared with Sensex's 4.51% fall. The scrip had also underperformed the market in past one quarter, declining 20.52% as against Sensex's 10.45% fall.

The small-cap company has equity capital of Rs 18.16 crore. Face value per share is Rs 2.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex APIs as well as dosage forms.

Previous News
  Unichem Laboratories reports consolidated net profit of Rs 83.99 crore in the December 2023 quarter
 ( Results - Announcements 05-Feb-24   14:52 )
  Board of Unichem Laboratories appoints director
 ( Corporate News - 20-Mar-23   11:16 )
  Unichem Laboratories schedules board meeting
 ( Corporate News - 01-Aug-22   15:58 )
  Sun Pharmaceuticals Industries Ltd Falls 1.71%
 ( Hot Pursuit - 20-Jun-24   09:30 )
  Unichem Lab hit all time high on USFDA nod for hypertension drug
 ( Hot Pursuit - 11-Jan-24   12:58 )
  Unichem Laboratories receives USFDA approval for Doxazosin tablets
 ( Corporate News - 11-Jan-24   12:04 )
  Unichem Laboratories reports consolidated net loss of Rs 17.19 crore in the March 2020 quarter
 ( Results - Announcements 19-Jun-20   14:23 )
  Unichem Laboratories receives USFDA approval for Guanfacine Tablets
 ( Corporate News - 04-Mar-21   17:30 )
  Unichem Laboratories to hold board meeting
 ( Corporate News - 26-Oct-21   11:45 )
  Unichem Lab rises after USFDA approval for Tadalafil tablets
 ( Hot Pursuit - 28-Mar-19   11:20 )
  Unichem Laboratories receives USFDA approval for Tadalafil Tablets
 ( Corporate News - 27-Mar-19   18:07 )
Other Stories
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top